Soleno Therapeutics (SLNO) Other Working Capital Changes: 2013-2024
Historic Other Working Capital Changes for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to $750,000.
- Soleno Therapeutics' Other Working Capital Changes fell 120.79% to -$42,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$360,000, marking a year-over-year decrease of 700.00%. This contributed to the annual value of $750,000 for FY2024, which is 10.39% down from last year.
- According to the latest figures from FY2024, Soleno Therapeutics' Other Working Capital Changes is $750,000, which was down 10.39% from $837,000 recorded in FY2023.
- In the past 5 years, Soleno Therapeutics' Other Working Capital Changes ranged from a high of $837,000 in FY2023 and a low of -$302,000 during FY2022.
- Moreover, its 3-year median value for Other Working Capital Changes was $750,000 (2024), whereas its average is $428,333.
- In the last 5 years, Soleno Therapeutics' Other Working Capital Changes tumbled by 147.91% in 2021 and then spiked by 377.15% in 2023.
- Yearly analysis of 5 years shows Soleno Therapeutics' Other Working Capital Changes stood at $549,000 in 2020, then crashed by 147.91% to -$263,000 in 2021, then declined by 14.83% to -$302,000 in 2022, then spiked by 377.15% to $837,000 in 2023, then declined by 10.39% to $750,000 in 2024.